# A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis

> **NCT06443502** · PHASE3 · RECRUITING · sponsor: **Takeda** · enrollment: 30 (estimated)

## Conditions studied

- Pouchitis

## Interventions

- **DRUG:** Vedolizumab
- **DRUG:** Concomitant Antibiotic Therapy

## Key facts

- **NCT ID:** NCT06443502
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-19
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06443502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06443502, "A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06443502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*